- Trends in medical use of opioids in the U.S., 2006–2016
- Usefulness of high dose oral flecainide for termination of recent onset atrial fibrillation in children
- Randomized phase II trial of carboplatin-paclitaxel vs carboplatin-paclitaxel-trastuzumab in uterine serous carcinomas that overexpress human epidermal growth factor receptor 2/neu
- Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer
- Association of inhaled corticosteroids and long-acting muscarinic antagonists with asthma control in patients with uncontrolled, persistent asthma: A systematic review and meta-analysis
- Dual antiplatelet therapy in transient ischemic attack and minor stroke with different infarction patterns: Subgroup analysis of CHANCE randomized clinical trial
- Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy vs concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma
- A randomized controlled trial to compare the effects of sulphonylurea gliclazide MR (modified release) and the DPP-4 inhibitor vildagliptin on glycemic variability and control measured by continuous glucose monitoring (CGM) in Brazilian women with type 2 diabetes
- Thiazolidinediones and risk of atrial fibrillation among patients with diabetes and coronary disease
- High efficacy of sofosbuvir/velpatasvir and impact of baseline resistance-associated substitutions in hepatitis C genotype 3 infection
- Adjunct targeted biologic inhibition agents to treat aggressive multivessel intraluminal pediatric pulmonary vein stenosis
- Vapocoolant spray vs placebo spray/no treatment for reducing pain from intravenous cannulation: A meta-analysis of randomized controlled trials
- Persistent tachycardia in clozapine treated patients: A 24-hour ambulatory electrocardiogram study
- Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: A single-arm, open-label, phase 1/2 trial
- Add-on antihypertensive medications to angiotensin-aldosterone system blockers in diabetes: A comparative effectiveness study
Feed Sources
